Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Certara
CERT
$1.25B
| $745K | ﹤0.01% |
40,917
+3,880
| +10% | +$81.9K |
|
|
AGNT
2427
AGNT Inc
AGNT
$669M
| $745K | ﹤0.01% |
36,722
+1,209
| +3% | +$18.1K |
|
2428
Petrobras Class A
PBR.A
$105B
| $744K | ﹤0.01% |
60,177
-147
| -0.2% | -$1.6K |
|
2429
American Vanguard Corp
AVD
$72.7M
| $742K | ﹤0.01% |
41,542
+3,966
| +11% | +$73.3K |
|
2430
Skillsoft
SKIL
$75M
| $739K | ﹤0.01% |
29,798
-9,145
| -23% | -$267K |
|
|
MODN
2431
DELISTED
MODEL N, INC.
MODN
| $737K | ﹤0.01% |
20,854
-7,486
| -26% | -$241K |
|
2432
DNOW Inc
DNOW
$2.6B
| $737K | ﹤0.01% |
71,115
+8,321
| +13% | +$83.6K |
|
|
PRDS
2433
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $735K | ﹤0.01% |
405,819
+388,241
| +2,209% | +$710K |
|
2434
Cars.com
CARS
$670M
| $734K | ﹤0.01% |
37,039
-4,011
| -10% | -$75.4K |
|
2435
PC Connection
CNXN
$2.17B
| $733K | ﹤0.01% |
16,251
-389
| -2% | -$17K |
|
|
ZUO
2436
DELISTED
Zuora, Inc.
ZUO
| $731K | ﹤0.01% |
66,662
-42,452
| -39% | -$402K |
|
2437
Interface
TILE
$2.05B
| $731K | ﹤0.01% |
83,189
+20,818
| +33% | +$160K |
|
2438
Life Time Group Holdings
LTH
$10.1B
| $730K | ﹤0.01% |
37,129
+15,779
| +74% | +$302K |
|
2439
Fomento Económico Mexicano
FMX
$42.3B
| $729K | ﹤0.01% |
6,578
-4,909
| -43% | -$494K |
|
2440
Collegium Pharmaceutical
COLL
$1.16B
| $728K | ﹤0.01% |
33,880
-769
| -2% | -$17.5K |
|
2441
NextDecade
NEXT
$1.71B
| $727K | ﹤0.01% |
88,550
-1,321
| -1% | -$8.11K |
|
2442
Brady Corp
BRC
$4.62B
| $725K | ﹤0.01% |
15,241
-8,939
| -37% | -$449K |
|
2443
Quanex
NX
$959M
| $723K | ﹤0.01% |
26,941
-1,357
| -5% | -$30.2K |
|
2444
Sinclair Inc
SBGI
$1.01B
| $723K | ﹤0.01% |
52,321
+5,249
| +11% | +$86.7K |
|
2445
Ooma
OOMA
$590M
| $723K | ﹤0.01% |
48,288
-5,471
| -10% | -$72K |
|
|
HGAS
2446
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
| $719K | ﹤0.01% |
72,163
| – | – |
|
|
EQRX
2447
DELISTED
EQRx, Inc. Common Stock
EQRX
| $716K | ﹤0.01% |
384,847
-59,977
| -13% | -$107K |
|
2448
Medifast
MED
$140M
| $716K | ﹤0.01% |
7,767
-2,849
| -27% | -$254K |
|
2449
AdaptHealth
AHCO
$873M
| $712K | ﹤0.01% |
58,474
+6,657
| +13% | +$74.2K |
|
2450
PUT
Chegg
CHGG
$120M
| $710K | ﹤0.01% |
+80,000
| New | +$970K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.